The Ministry of Health reported that the Vaccine Advisory Committee approved opening booster vaccination in population over 18 years of age.
To access this third dose (in cases of the initial two-dose vaccine) or the second (in single-dose vaccines), people they must complete six months of having applied the initial scheme.
From this Wednesday, November 24, health personnel, their logistical support, traditional doctors, ancestral experts, pilots and national crew who transfer patients and other groups prioritized in Decree 630 of 2021 may apply the booster dose if they comply with the term.
“The incorporation of all adults aged 18 and over to the assignment of boosters contributes to herd immunity, considering the appearance of more contagious variants, some of them with the potential to evade the immune response“, explained the Minsalud.
Yes indeed, “Despite the low involvement, the risk of having a new peak is not eliminated”, Highlighted the entity.
SCHEDULE
The booster dose will be given in a progressive as they go through the different stages.
In the case d#In the first and second stage population, which according to the opening date must have already completed six months of completing their scheme, they can now obtain the reinforcement. There are even some of the stage 3 population who already receive it.
But there are set dates. For instance, the population group of stage 3 the reinforcement process would begin on December 21, 2021. The group that makes up the fourth stage, that is to say, citizens over 40 years of age, it would start on January 18, 2022; and the stage 5, It would start on February 16, 2022.
The Vaccine Advisory Committee also recommended the use of platforms heterologous, that is, vaccines different from those administered in the initial schedule. (Homologous It is the same vaccine as the first scheme).
That is to say: populations will be able to access a booster dose with a biological homologous, when the initial scheme used was inactivated virus, viral vector or mRNA. Or with a heterologous biological, with mRNA platform or viral vector (AstraZeneca), when the initial scheme was mRNA platform vector, viral vector or inactivated virus). The following table will illustrate it better:
Table for the booster shot.
Private file
In the case of vaccinated abroad this will apply if:
– If you are part of the population in stages 1 and 2, you can now access the boost.
– If you are under 50 years old, you must wait six months after completing your booster vaccination schedule.
– If you are over 50 years old, you must wait until four months after completing your scheme.
BRIEFCASE
